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Abstract 
Introduction: Although the synergistic effects of opioids and other analgesic drugs such as non-steroidal anti-
inflammatory drugs (NSAIDs) have been established in relieving acute pain due to renal calculi, no studies today 
have evaluated the concomitant administration of opiates and other drugs with analgesic effects, such as seroto-
nin re-uptake inhibitors. Considering the high prevalence of renal colic, the present study was carried out to com-
pare the effect of concomitant prescription of morphine and a placebo with that of morphine and citalopram on 
the management of acute pain due to renal calculi. Methods: The present double-blind randomized clinical trial 
was carried out from October 2012 to March 2013 in the Al-Zahra educational Hospital in Isfahan, Iran. 90 pa-
tients with acute renal colic pain were randomly divided into two groups of 45 subjects. The subjects in one group 
received morphine/ placebo and another one morphine/citalopram. The patients’ pain severity was determined 
by visual analogue scale (VAS) before and 20 minutes after administration of medications. In case of persistent 
pain, the second or even third dose was administered and the pain severity was once again determined. Data 
were analyzed with STATA 11.0 using chi-squared, two-way ANOVA, Bonferroni post hoc test, and log rank test. 
Results: The decrease in pain severity in the morphine/citalopram group was significantly compared to the mor-
phine/placebo group and the time before administration of the medications (p<0.001). In contrast, administra-
tion of morphine/placebo did not have a significant effect on pain severity at this interval (p=0.32). Kaplan-Meier 
curve showed that the first injection was successful in relieving pain in 15 (33.3%) and 26 (57.8%) subjects in the 
morphine/placebo and morphine/citalopram groups, respectively. The second injection of these medications re-
sulted in therapeutic success in 35 (87.8%) and 42 (95.6%) subjects in the above groups, respectively. Log rank 
test showed a significant difference in the treatment success between the two groups (p=0.001). Conclusion: It 
seems that the combination of citalopram and morphine sulfate causes increased efficacy and higher success rate 
in pain control of patients presented to the emergency department with a complaint of renal colic. 
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Introduction:1 
enal colic is usually manifested clinically as a 
very painful and troublesome condition which 
appears unilaterally on the flank to the groin 
suddenly or periodically (1, 2). The condition afflicts 5-
12% of the population in industrial societies at least 
once in their life and its recurrence rate is approximate-
ly 50% (1). The pain is usually attributed to contraction 
of ureter soft muscles in response to the presence of 
stone (3-5). Therefore, the most important considera-
tion in the emergency management of renal colics is 
pain control/relief (5, 6). Various therapeutic strategies 
are employed to alleviate the pain due to renal calculi 
and some studies have recommended the use of NSAID, 
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especially ketorolac, as the first analgesic for renal cal-
culi (5, 7-10). However, disadvantages such as lack of 
availability, high cost, the risk of gastrointestinal hem-
orrhage, and acute renal insufficiency have led to a 
greater use of opioids such as meperidine and mor-
phine or their concomitant use in clinical settings com-
pared to NSAIDs (1, 11, 12). On the other hand, there is 
an ample evidence in relation to pain relief with the use 
of serotonin re-uptake inhibitors such as citalopram in 
patients with acute and chronic renal insufficiency, in 
cases of visceral pain, heat sensitivity, thermal pain, 
peritoneal dialysis, peritonitis and neuropathic injuries 
(13, 14). Although the synergistic effects of opioids such 
as morphine and the group of analgesics such as 
NSAIDs have been established on relieving acute pain 
due to renal stones, no studies today have evaluated the 
effects of concomitant administration of opioids and 
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hibitions. Therefore, the present study was undertaken 
to evaluate the presence or absence of synergistic or 
additive analgesic effect of morphine and citalopram on 
relieving acute renal stone pain. 
Methods: 
Study design and setting 
The present double-blind randomized clinical trial was 
carried out during a six-month period from October 
2012 to March 2013 in the emergency department of 
Al-Zahra Hospital, Isfahan, Iran. The protocol of the 
study was prepared based on Helsinki declaration and 
approved by ethics committee of Isfahan University of 
Medical Sciences. The study was registered in Iranian 
registry of clinical trial (IRCT2014020812072N1). All 
patients signed consent form before including to the 
study.  
Participants 
The subjects were patients with acute renal colic, refer-
ring to the emergency department of Al-Zahra Hospital. 
The inclusion criteria consisted of an age range of 18-
55, a clinical diagnosis of acute colicky pain, pain severi-
ty of 7-10 based on visual analogue scale (VAS), and 
patients’ consent form to participate in the study. The 
exclusion criteria consisted of pregnancy or suspected 
of being pregnant, contraindication in relation to taking 
morphine and citalopram based on drug catalog, a his-
tory of dependence on opioids or SSRIs, receiving an 
analgesic during a six-hours period before presentation, 
peritonitis or peritoneal symptoms and signs, any dis-
ease preventing communication, and patient’s decision 
to leave the study.  
Intervention 
All the patients underwent a urine analysis and an ul-
trasound examination. The final diagnosis was reached 
in each patient based on initial clinical diagnosis using 
the examinations above. The patients were randomly 
assigned to two groups. The subjects in group one re-
ceived an intravenous injection consisting of 5 mg of 
morphine sulfate plus placebo (normal saline with the 
same volume as that in group two) and subjects in 
group two received an intravenous injection consisting 
of 5 mg of morphine sulfate plus 20 mg of citalopram. 
During the study period, none of the patients, physi-
cians and nurses, and the medical care team members 
were aware of the study procedures. Preparation and 
injection of medications were carried out by two nurs-
es; the nurses prepared the medications were blind to 
drugs of each patient.  All the syringes had the same 
shape. Randomization and registration of data were 
carried out by the chief researcher who was the only 
person aware of the study procedures. In order to con-
firm the diagnosis, all the patients were subjected to an 
ultrasound examination of kidneys and the urinary 
tract. The ultrasonography was not performed for pa-
tients with a documented history of renal calculi or pa-
tients recovering from renal calculi and referring with a 
similar episode. Visualization of a renal stone by a radi-
ologist during ultrasound examination or a report of 
hydronephrosis on the painful side confirmed the diag-
nosis. Passage of stone through the urethra and direct 
visualization of stone confirmed the diagnosis, too. The 
medications were administered intravenously in the 
same manner for all the patients and each of them re-
ceived a proper medications dose based on a timetable. 
Any drug side effect was managed by standard proto-
cols of the emergency department.   
Statistical analyses  
The sample size in the present study was calculated at 
45 subjects in each group, by considering a 95% confi-
dence interval, an 80% power of the test, the variance 
of pain severity 1.7, and the minimum significant differ-
ence 0.8. Data were analyzed using STATA ver. 11.0. 
Independent t-test and chi-squared test were used to 
evaluate the quantitative and qualitative variables, re-
spectively. Two-way ANOVA and Bonferroni post hoc 
test were applied to assess inter- and intra-group dif-
ferences in pain severity based on VAS at study inter-
vals. Kaplan-Meier estimates were used to evaluate 
treatment success and log rank test to compare the 
treatment regiments. To this end, treatment success 
was defined as a decrease in pain severity at least three 
points on VAS. Statistical significance was defined at 
P<0.05.  
Results: 
Ninety patients with acute colicky pain were equally 
assigned to two groups for treatment with morphine + 
placebo and morphine/citalopram. The mean ages of 
the subjects in two groups were 35.36±9.5 and 
35.56±10.4 years, respectively (p=0.92). In the mor-
phine/placebo and morphine/citalopram groups, 33 
(73.3%) and 32 (71.1%) subjects were male, respec-
tively (p=0.92). The mean VAS at the time of admission 
in the morphine/placebo and morphine/citalopram 
groups were 7.53±1.66 and 7.07±1.85, respectively 
(p=0.22). Twenty minutes after the first injection, the 
mean VAS decreased to 6.4±2.3 and 4.0±3.1 in the mor-
phine/placebo and morphine/citalopram groups, re-
spectively. The decrease in pain severity in the mor-
phine/citalopram group was significantly compared to 
the morphine/placebo group and the time before ad-
ministration of the medications (baseline) (p<0.001). In 
contrast, administration of morphine and placebo did 
not have a significant effect on pain severity at this in-
terval (p=0.32). The mean pain severity 20 minutes af-
ter the second injection meaningfully decreased (40 
minutes after the first injection) in the mor-
phine/citalopram group [mean (SD)= 1.6 (1.6); p< 
0.001] and in the morphine/placebo group [mean (SD)= 
2.31 (1.72); p<0.001]. Pain severity was not considera-
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The third injection did not have any extra effect on pain 
intensity in both groups (p>0.99) (Figure 1). Two-way 
ANOVA showed that the therapeutic interventions re-
sulted in a significant decrease in pain severity (df: 1.7; 
F=66.9; p<0.001). Kaplan-Meier curve showed that the 
first injection was successful in relieving pain in 15 
(33.3%) and 26 (57.8%) subjects in the morphine/ pla-
cebo and morphine/citalopram groups, respectively. 
The second injection of these medications resulted in 
therapeutic success in 35 (87.8%) and 42 (95.6%) sub-
jects in the above groups, respectively. Log rank test 
showed a remarkable difference in the treatment suc-
cess between the two groups (p=0.001) (Figure 2). 
Discussion: 
Based on the findings of present study, combination of 
morphine sulfate and citalopram has significantly high-
er success rate in pain control of renal colic during the 
first 20-minute period in comparison to morphine 
alone. However, administration of morphine and place-
bo did not have a noteworthy effect on pain severity at 
this interval. There were no meaningful differences in 
the second and third dose administrations between two 
groups regarding changes in pain severity (figure 1). 
But, the results of the log rank test revealed a signifi-
cantly higher success rate in morphine/citalopram 
group at the same time. It means that, although the two 
groups were able to equal changes in pain severity dur-
ing a 60-minute period, but the failure rate was consid-
erably higher in patients received morphine alone.  
Previous studies have shown that use of morphine re-
sults in an increase of serotonin levels in the brain; also, 
use of citalopram increases serotonin concentration by 
inhibiting its re-uptake (15). On the other hand, the 
tranquilizing effect of citalopram helps relieving pain in 
these patients. Sacerdote et al. concluded that the anal-
gesic effect of some antidepressant seems to be related 
to an activation of the endogenous opioid system medi-
ated by serotonin (16). Therefore, it seems that the 
combination of a serotonin re-uptake inhibitor and 
morphine sulfate have synergistic effects regarding 
pain control. Since citalopram has a minimum side ef-
fects compared to other inhibitors of serotonin re-
uptake inhibitors, it could be considered as a suitable 
choice for this object. Campo and their colleague re-
vealed the potential effects of citalopram for functional 
pediatric recurrent abdominal pain control (17). A ran-
domized double-blind study showed a moderate anal-
gesic effect of citalopram in patients with Pain disorder 
and declared that it appears to be not correlated to 
changes in depressive scores (18). Also, citalopram had 
a positive effect on chronic pelvic pain control and re-
lieving peripheral neuropathic pain in diabetic patients 
(19, 20).  The present study showed that citalopram in 
combination with morphine causes to increase the effi-
cacy of morphine in relieving the pain of renal colic. 
Further studies are needed to evaluate of action mech-
anisms and potential complications  
Limitation 
Although the VAS is a standard scoring system for eval-
uation of pain severity, the use of functional (21) and 
behavioral (22) indices, as an adjunct to VAS, could be 
more accurate. However, the study power of 99% made 
the findings of the study valid. 
Conclusion: 
It seems that the combination of citalopram and mor-
  
Figure 1: Time trend of pain severity in the mor-
phine/placebo and morphine/citalopram groups. Data were 
presented as means and standard errors. * Significant differ-
ence compared to the period before treatment at P<0.001; # 
Significant difference with same time in the mor-
phine/placebo group at P<0.001.  
Figure 2: The Kaplan-Meier curve to show the success rate in 
patients’ underling treatment with two drug regimens of mor-
phine + placebo and morphine + citalopram. Log rank test 
showed a significant difference in treatment success between 




























































45 19 (42.2%) 2 (4.4%) 2 (4.4%)Morphine + Citalopram
45 30 (66.7%) 10 (22.2%) 10 (22.2%)Morphine + Placebo
Number of failure
0 20 40 60
Time (minute)





 This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). 
Copyright © 2014 Shahid Beheshti University of Medical Sciences. All rights reserved. Downloaded from: www.jemerg.com 
 
29 Esmailian et al 
phine sulfate causes to an increased efficacy and higher 
success rate in pain control of patients presented to the 
emergency department with a complaint of renal colic. 
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